Nuo Therapeutics, Inc.
Industry
- Biotechnology
- Medical Devices
Other Names/Subsidiaries
- Aldagen, Inc.
- Cytomedix Inc.
See more in Biomedtracker
Latest on Nuo Therapeutics, Inc.
Scrip
• By Mandy Jackson
Aldea Pharmaceuticals will begin clinical trials in acute alcohol intoxication and Fanconi anemia for AD-6626, the company's lead drug candidate for aldehyde metabolism disorders, with $24m in Series
In Vivo
IN VITRO DIAGNOSTICS Mergers & Acquisitions Institut Merieux bioMerieux SA BioFire Diagnostics Inc. Leading diagnostics firm bioMerieux SA (a division of Institut Merieux ) has agreed to acquir
Scrip
• By Sukaina Virji
Cytomedix is to downsize its R&D activities in a renewed focus on profitability, in what is its second reorganization in as many months. As part of its latest initiative, the company's will "substanti